In vivo growth inhibition of leukemia by 4-amidinoindan-1-one 2′-amidinohydrazone (CGP 48664a), a new inhibitor of S-adenosylmethionine decarboxylase
✍ Scribed by Bernard Dorhout; Roelf Jakob Te Velde; Harri Ferwerdaanneke W. Kingma; Elly De Hoog; Frits A. J. Muskiet
- Book ID
- 102277925
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 391 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
We studied the in vivo growth-inhibitory effect of the new S-adenosylmethionine decarboxylase inhibitor 4-amidinoindan-I-one 2'-amidinohydrazone (CGP 48664A). LI2IO-bearing DBA-2 mice were treated with increasing CGP 48664A doses from I day after i.p. L1210 cell inoculation. Treatment was continued for 4 days, after which all mice were killed. CGP 48664A caused dose-related exponential decreases of L I 2 I 0 cell numbers and spermidine and spermine contents. Putrescine contents increased exponentially. Polyamine changes in spleen and liver were less profound. LIZ10 growth inhibition
📜 SIMILAR VOLUMES
## Abstract We studied the in vivo effects of 4‐amidinoindan‐l‐one 2′‐amidinohydrazone (CGP 48664A), α‐difluoromethylornithine (DFMO) and a combination of CGP 48664A‐DFMO on tumor growth, cell‐cycle phase distribution and polyamine contents. DBA‐2 mice were inoculated i.p. with 10^5^ L1210 cells on